首页 | 本学科首页   官方微博 | 高级检索  
     


Deciphering radiological stable disease to immune checkpoint inhibitors
Authors:J. Luo  S. Wu  H. Rizvi  Q. Zhang  J.V. Egger  J.C. Osorio  A.J. Schoenfeld  A.J. Plodkowski  M.S. Ginsberg  M.K. Callahan  C. Maher  A.N. Shoushtari  M.A. Postow  M.H. Voss  R.R. Kotecha  A. Gupta  R. Raja  M.G. Kris  M.D. Hellmann
Affiliation:1. Thoracic Oncology Service, Memorial Sloan Kettering Cancer Center, New York, USA;2. Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, USA;3. Department of Medicine, Harvard Medical School, Boston, USA;4. Translational Medicine Oncology, AstraZeneca, Gaithersburg, USA;5. Druckenmiller Center for Lung Cancer Research, Memorial Sloan Kettering Cancer Center, New York, USA;6. Department of Medicine, Weill Cornell Medical Center, New York, USA;7. Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, USA;8. Parker Institute for Cancer Immunotherapy at Memorial Sloan Kettering Cancer Center, New York, USA;9. Melanoma Service, Memorial Sloan Kettering Cancer Center, New York, USA;10. Genitourinary Oncology Service, Memorial Sloan Kettering Cancer Center, New York, USA;11. Global Medicines Development, AstraZeneca, Gaithersburg, USA
Abstract:
Keywords:immunotherapy/checkpoint blockade  RECIST  lung cancer
本文献已被 ScienceDirect 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号